Phil Franchina, Author at American Parkinson Disease Association

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s

Posted on February 5, 2025February 5, 2025 by Phil Franchina

ONAPGOTM: A Newly-Approved Medication for OFF Periods in Parkinson’s Breaking News! The first subcutaneous (under the skin) apomorphine infusion,...see more now called ONAPGOTM, was approved by the Food and Drug Administration (FDA) on February 4, 2025. Apomorphine is a dopamine agonist whose effects have a rapid onset. It has been available in the US as a […]

HAND IN HAND: THE ESSENTIAL SUPPORT OF PARKINSON’S CARE PARTNERS

Posted on January 8, 2025January 22, 2025 by Phil Franchina

Care partners are the heart of support for people...see more living with Parkinson’s — providing love, companionship, and a steady hand through every twist and turn of the journey. They bring a sense of safety, trust, and connection, enriching the lives of their loved ones. Whether […]

WHAT’S HAPPENING AT APDA

Posted on January 8, 2025January 22, 2025 by Phil Franchina

Registration is open! The third annual APDA Virtual Parkinson’s Conference will take place February 19-20,...see more and registration is now open! This is a do-not-miss program with something for everyone! Reserve your spot today and get ready for two days of the very latest PD info, hot topics, inspiration, community, and more! […]

RECONNECT FOR VALENTINE’S DAY WITH APDA’S PARKINSEX

Posted on January 8, 2025January 8, 2025 by Phil Franchina

Romance, intimacy, and special connection can often take a backseat to Parkinson’s...see more disease. Life with PD can be challenging, and it can feel busy and overwhelming, especially as symptoms change or increase. For those who have a significant other, you might be missing the tender touches, spicy moments, […]

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

Posted on January 8, 2025January 9, 2025 by Phil Franchina

Q: I was recently told that carbidopa/ levodopa doesn’t help tremor. Is...see more that true? A: No. Carbidopa/levodopa often helps tremor. However, in a certain percentage of people, tremors don’t respond well as other symptoms of PD such as slowness and stiffness. Movement disorder physicians measure whether medication doses […]

CHAMPIONING HEALTH EQUITY: RESEARCHER’S QUEST TO EXPAND ADVANCE CARE PLANNING IN HISPANIC PD COMMUNITIES

Posted on January 8, 2025January 22, 2025 by Phil Franchina

As part of our 2024-2025...see more research funding, the American Parkinson Disease Association (APDA) was proud to award Danielle Shpiner, MD, an APDA Diversity in Parkinson’s Disease Research Grant, which is given to investigators exploring health inequities and/or differences among under-studied Parkinson’s […]

AMERICAN PARKINSON DISEASE ASSOCIATION FREE TWO-DAY VIRTUAL CONFERENCE RETURNS TO EDUCATE, EMPOWER, AND ENGAGE THE PD COMMUNITY

Posted on January 6, 2025January 22, 2025 by Phil Franchina

Two days of learning, activities, and inspiration featuring top expertsFebruary 19 & 20, 2025 NEW YORK, NY, JANUARY 6,...see more 2025 – The American Parkinson Disease Association (APDA) is pleased to announce that registration is open for its third annual APDA Virtual Parkinson’s Conference. Following the overwhelming success of its first two years – which combined […]

EPA Bans TCE, a Solvent Linked to PD

Posted on December 11, 2024December 11, 2024 by Phil Franchina

In an exciting development for the Parkinson’s disease (PD) community, the Environmental Protection Agency (EPA) banned two solvents, trichloroethylene...see more (TCE) and perchloroethylene, that are found in many common industry and household products such as cleaners, lubricants, and glue. Both have been found to contribute to the increased risk of various cancers and other health conditions. […]

Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations

Posted on October 23, 2024November 18, 2024 by Phil Franchina

Breaking news! The first subcutaneous (under the skin) 24-hour infusion...see more of foslevodopa/foscarbidopa under the brand name Vyalev, was approved by the Food and Drug Administration on Oct 17, 2024. Produced by AbbVie, this medication for the treatment of motor fluctuations in Parkinson’s disease (PD) has already […]

MAKING HOPE POSSIBLE: APDA FUNDS INNOVATIVE RESEARCH

Posted on September 27, 2024October 7, 2024 by Phil Franchina

From genetic causes of PD to the neurobiology of cognitive dysfunction, APDA-funded...see more researchers begin new work. The American Parkinson Disease Association (APDA) recently awarded $2.6 million to support innovative Parkinson’s disease (PD) research for the 2024-2025 funding year. Exciting projects will tackle a wide range of key areas […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s

HAND IN HAND: THE ESSENTIAL SUPPORT OF PARKINSON’S CARE PARTNERS

WHAT’S HAPPENING AT APDA

RECONNECT FOR VALENTINE’S DAY WITH APDA’S PARKINSEX

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

CHAMPIONING HEALTH EQUITY: RESEARCHER’S QUEST TO EXPAND ADVANCE CARE PLANNING IN HISPANIC PD COMMUNITIES

AMERICAN PARKINSON DISEASE ASSOCIATION FREE TWO-DAY VIRTUAL CONFERENCE RETURNS TO EDUCATE, EMPOWER, AND ENGAGE THE PD COMMUNITY

EPA Bans TCE, a Solvent Linked to PD

Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations

MAKING HOPE POSSIBLE: APDA FUNDS INNOVATIVE RESEARCH

She was diagnosed with Parkinson’s at 27. These were her warning signs.

Wearable Devices for Parkinson’s Disease: The Future Is Here

Food as Medicine: Diet’s Role in Parkinson’s Disease

Is Parkinson’s Disease Hereditary?

AMERICAN PARKINSON DISEASE ASSOCIATION FREE TWO-DAY VIRTUAL CONFERENCE RETURNS TO EDUCATE, EMPOWER, AND ENGAGE THE PD COMMUNITY

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON'S ACT BECOMING LAW

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s

EPA Bans TCE, a Solvent Linked to PD

Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations

Adaptive DBS – a new approach to improve PD symptoms

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!